IL-3, IL-5, granulocyte-macrophage colony-stimulating factor receptor alpha-subunit, and common beta-subunit expression by peripheral leukocytes and blood dendritic cells.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Journal of Allergy and Clinical Immunology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 9600506
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cytokine receptors and signal transduction.

  2005cited by this paper
• Expression of high-affinity IgE receptors (Fc epsilon RI) on peripheral blood basophils, monocytes, and eosinophils in atopic and nonatopic subjects: relationship to total serum IgE concentrations.

  1997cited by this paper
• Characterization of human leucocytes bearing the IL-3 receptor.

  1996cited by this paper
• Monoclonal antibody 7G3 recognizes the N-terminal domain of the human interleukin-3 (IL-3) receptor alpha-chain and functions as a specific IL-3 receptor antagonist.

  1996cited by this paper
• Human interleukin-3 (IL-3) induces disulfide-linked IL-3 receptor alpha- and beta-chain heterodimerization, which is required for receptor activation but not high-affinity binding

  1996cited by this paper
• Human B cells express IL-5 receptor messenger ribonucleic acid and respond to IL-5 with enhanced IgM production after mitogenic stimulation with Moraxella catarrhalis.

  1996cited by this paper
• Peripheral blood dendritic cells express Fc epsilon RI as a complex composed of Fc epsilon RI alpha- and Fc epsilon RI gamma-chains and can use this receptor for IgE-mediated allergen presentation.

  1996cited by this paper
• Flow cytometric analysis of cytokine receptors on human Langerhans' cells. Changes observed after short‐term culture

  1996cited by this paper
• The role of alveolar macrophages and dendritic cells in allergic airway sensitization

  1996cited by this paper
• Multi-colony stimulating activity of interleukin 5 (IL-5) on hematopoietic progenitors from transgenic mice that express IL-5 receptor alpha subunit constitutively

  1995cited by this paper
• Cytokine receptor signalling

  1995cited by this paper
• Identification of Key Charged Residues of Human Interleukin-5 in Receptor Binding and Cellular Activation (*)

  1995cited by this paper
• Neutrophils activated by granulocyte-macrophage colony-stimulating factor express receptors for interleukin-3 which mediate class II expression.

  1995cited by this paper
• The degradation product of the C5a anaphylatoxin C5adesarg retains basophil‐activating properties

  1994cited by this paper
• Understanding the dendritic cell lineage through a study of cytokine receptors

  1994cited by this paper
• Expression and factor-dependent modulation of the interleukin-3 receptor subunits on human hematopoietic cells.

  1993cited by this paper
• Differentiation and proliferation of hematopoietic stem cells.

  1993cited by this paper
• Receptors for granulocyte-macrophage colony-stimulating factor, interleukin-3, and interleukin-5.

  1993cited by this paper
• Rapid priming of human monocytes by human hematopoietic growth factors: granulocyte-macrophage colony-stimulating factor (CSF), macrophage-CSF, and interleukin-3 selectively enhance superoxide release triggered by receptor-mediated agonists.

  1992cited by this paper
• Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage.

  1992cited by this paper
• GM-CSF, IL-3 and IL-5: cross-competition on human haemopoietic cells.

  1992cited by this paper
• Residue 21 of human granulocyte‐macrophage colony‐stimulating factor is critical for biological activity and for high but not low affinity binding.

  1992cited by this paper
• Interleukin-5, eosinophils, and disease.

  1992cited by this paper
• Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma.

  1991cited by this paper
• Interleukin-5, interleukin-3, and granulocyte-macrophage colony-stimulating factor cross-compete for binding to cell surface receptors on human eosinophils.

  1991cited by this paper
• Characterization of the human IL-5 receptors on eosinophils.

  1991cited by this paper
• Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5, and granulocyte/macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects

  1991cited by this paper
• High affinity human IgE receptor (Fc epsilon RI). Analysis of functional domains of the alpha-subunit with monoclonal antibodies.

  1991cited by this paper
• T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma.

  1991cited by this paper
• Regulatory effect of cytokines on eosinophil degranulation.

  1990cited by this paper
• Regulation of surface expression of the granulocyte/macrophage colony-stimulating factor receptor in normal human myeloid cells.

  1990cited by this paper
• Human Interleukin‐3 inhibits the binding of granulocyte‐macrophage colony‐stimulating factor and interleukin‐5 to basophils and strongly enhances their functional activity

  1990cited by this paper
• Interleukin 5 modifies histamine release and leukotriene generation by human basophils in response to diverse agonists

  1990cited by this paper
• Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3.

  1988cited by this paper
• Recombinant human interleukin 5 is a selective activator of human eosinophil function

  1988cited by this paper
• Regulation of human eosinophil viability, density, and function by granulocyte/macrophage colony-stimulating factor in the presence of 3T3 fibroblasts

  1987cited by this paper

• Interleukin‐5 as a pleiotropic cytokine orchestrating airway type 2 inflammation: Effects on and beyond eosinophils

  2024cites this paper
• Basophils in pruritic skin diseases

  2023cites this paper
• Blood transcriptomic signature in type-2 biomarker low severe asthma and asthma control.

  2023cites this paper
• Eosinophil-mediated suppression and Anti-IL-5 enhancement of plasmacytoid dendritic cell interferon responses in asthma.

  2022cites this paper
• Modulation of blood inflammatory markers by benralizumab in patients with eosinophilic airway diseases

  2019cites this paper
• A Review of Three New Anti-interleukin-5 Monoclonal Antibody Therapies for Severe Asthma

  2018cites this paper
• Immunological and hematological effects of IL‐5(Rα)‐targeted therapy: An overview

  2018cites this paper
• The association between blood eosinophil count and benralizumab efficacy for patients with severe, uncontrolled asthma: subanalyses of the Phase III SIROCCO and CALIMA studies

  2017cites this paper
• Targeting IL-5Rα with antibody-conjugates reveals a strategy for imaging and therapy for invasive bladder cancer

  2017cites this paper
• Physiology and Pathology of Innate Immune Response Against Pathogens

  2017cites this paper
• Biomarkers in the clinical development of asthma therapies.

  2016cites this paper
• Targeting key proximal drivers of type 2 inflammation in disease

  2015cites this paper
• IL-5 induces suspended eosinophils to undergo unique global reorganization associated with priming.

  2014cites this paper
• High Yield Production of a Soluble Human Interleukin-3 Variant from E. coli with Wild-Type Bioactivity and Improved Radiolabeling Properties

  2013cites this paper
• Emerging Role of Human Basophil Biology in Health and Disease

  2013cites this paper
• Targeting interleukins to treat severe asthma

  2012cites this paper
• Protein-Protein Interaction Analysis Highlights Additional Loci of Interest for Multiple Sclerosis

  2012cites this paper
• Flow cytometry analysis of leukocytes in induced sputum from asthmatic patients.

  2012cites this paper
• What targeting the eosinophil has taught us about their role in diseases

  2010cites this paper
• What targeting eosinophils has taught us about their role in diseases.

  2010cites this paper
• Effect of inhaled interleukin‐5 on eosinophil progenitors in the bronchi and bone marrow of asthmatic and non‐asthmatic volunteers

  2007cites this paper
• Discovery and characterization of a novel splice variant of the GM-CSF receptor alpha subunit.

  2007cites this paper
• Correlation between Eosinophils and Protection against Reinfection with Schistosoma mansoni and the Effect of Human Immunodeficiency Virus Type 1 Coinfection in Humans

  2006cites this paper
• Advances in fish cytokine biology give clues to the evolution of a complex network.

  2006cites this paper
• Effect of allergen-specific immunotherapy on recombinant human interleukin 3-mediated amplification of allergen-induced basophil histamine release.

  2005cites this paper
• Nerve growth factor influences IgE-mediated human basophil activation: functional properties and intracellular mechanisms compared with IL-3.

  2005cites this paper
• A role for eosinophils in airway remodelling in asthma.

  2004cites this paper
• Identification of Selective Basophil Chemoattractants in Human Nasal Polyps as Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor-21

  2004cites this paper
• Interleukin‐5 receptors on human lung eosinophils after segmental allergen challenge

  2004cites this paper
• Biology of common beta receptor-signaling cytokines: IL-3, IL-5, and GM-CSF.

  2003cites this paper
• Analysis of gene expression in peripheral blood eosinophils from patients with atopic dermatitis and in vitro cytokine‐stimulated blood eosinophils

  2003cites this paper
• Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway.

  2003cites this paper
• Comparative effects of basophil-directed growth factors.

  2003cites this paper
• Down‐regulated IL‐5 receptor expression on peripheral blood eosinophils from budesonide‐treated children with asthma

  2002cites this paper
• Granulocyte-macrophage colony-stimulating factor (GM-CSF) and inflammatory stimuli up-regulate secretion of the soluble GM-CSF receptor in human monocytes: evidence for ectodomain shedding of the cell surface GM-CSF receptor alpha subunit.

  2002cites this paper
• Identification of a novel dendritic cell‐like subset of CD64+ / CD16+ blood monocytes

  2001cites this paper
• Proteasomal regulation of betac signaling reveals a novel mechanism for cytokine receptor heterotypic desensitization.

  2001cites this paper
• Mast cells, basophils, and eosinophils: distinct but overlapping pathways for recruitment

  2001cites this paper
• Expression of renin-angiotensin system genes in immature and mature dendritic cells identified using human cDNA microarray.

  2001cites this paper
• The Role of Eosinophils in Asthma: Sarastro or the Queen of the Night?

  2001cites this paper
• Human recombinant histamine-releasing factor activates human eosinophils and the eosinophilic cell line, AML14-3D10.

  2000cites this paper
• The surface phenotype of human eosinophils.

  2000cites this paper
• Evidence for Local Eosinophil Differentiation Within Allergic Nasal Mucosa: Inhibition with Soluble IL-5 Receptor1

  2000cites this paper
• Attenuation of the allergen-induced late asthmatic reaction by cyclosporin A is associated with inhibition of bronchial eosinophils, interleukin-5, granulocyte macrophage colony-stimulating factor, and eotaxin.

  2000cites this paper
• Granulocyte–macrophage colony‐stimulating factor and interleukin‐3 cause basophil histamine release by a common pathway: downregulation by sodium

  1999cites this paper
• CD34(+)/interleukin-5Ralpha messenger RNA+ cells in the bronchial mucosa in asthma: potential airway eosinophil progenitors.

  1999cites this paper
• Granulocyte/Macrophage–Colony Stimulating Factor in Allergen–Induced Rhinitis: Cellular Localization, Relation to Tissue Eosinophilia and Influence of Topical Corticosteroid

  1998cites this paper